— Know what they know.
Not Investment Advice

TKNO NASDAQ

Alpha Teknova, Inc.
1W: +4.0% 1M: +20.2% 3M: +87.9% YTD: -0.8% 1Y: -42.4% 3Y: +94.5%
$3.89
+0.02 (+0.52%)
 
Weekly Expected Move ±11.4%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 64 · $208.6M mcap · 11M float · 1.17% daily turnover · Short 65% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$41M +7.4% ▲
5Y CAGR: +5.3%
Gross Profit
$13M +85.9% ▲
5Y CAGR: -5.4%
Operating Income
-$17M +35.1% ▲
Net Income
-$17M +35.5% ▲
EPS (Diluted)
$-0.32 +43.9% ▲
EBITDA
-$10M +48.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$37M$41M$37M$38M$41M
YoY Growth+17.9%+12.3%-11.4%+2.9%+7.4%
Cost of Revenue$19M$24M$26M$31M$27M
Gross Profit$18M$17M$10M$7M$13M
Gross Margin47.8%42.2%28.1%19.2%33.2%
R&D Expenses$4M$8M$6M$3M$2M
SG&A Expenses$24M$37M$35M$29M$27M
Operating Expenses$30M$67M$46M$33M$30M
Operating Income-$12M-$50M-$36M-$26M-$17M
Operating Margin-32.5%-119.9%-96.9%-69.3%-41.9%
Interest Expense$589K$0$833K$687K$710K
Income Before Tax-$13M-$49M-$37M-$27M-$17M
Tax Expense-$3M-$2M-$298K-$88K$58K
Net Income-$10M-$47M-$37M-$27M-$17M
Net Margin-26.6%-114.6%-100.3%-70.9%-42.6%
EPS (Diluted)$-0.35$-1.69$-1.16$-0.57$-0.32
EBITDA-$9M-$26M-$26M-$20M-$10M
Shares Outstanding28M28M32M47M53M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms